As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and next generation probiotics. The company was founded based on world leading science from the labs of Professor Fredrik Bäckhed and Professor Jens B Nielsen, to provide commercial access to metagenome research and development. MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Az Bioventure Hub, C/o Astrazeneca R&d Mölndal, Mölndal,västra Götaland S-43183,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- metabogen.com
- Keywords
- Metagenomic Research, Systems Biology, Biomarkers, Diagnostics, Patient stratification, Bacteria isolation and development, Next generation probiotics.
- HQ
- Mölndal, Västra Götaland
Metabogen Ab Questions
Metabogen Ab's website is metabogen.com
Metabogen Ab's LinkedIn profile is https://se.linkedin.com/company/metabogen-ab
Metabogen Ab has
1 employees.
View email and phone details for 1
employees at Metabogen Ab.
Metabogen Ab's industry is
Biotechnology Research
Metabogen Ab's top competitors are
Chrysea,
Biolamina,
Hansa Biopharma,
Mendus Ab,
Formulaex,
Alzinova Ab,
Elicera Therapeutics Ab,
Biogaia Ab,
Kromnigon,
Fluicell.
Metabogen Ab's categories are Biotechnology Research
Metabogen Ab's founding year is 2011
